Search

By Industry Solutions (2)
By Phase (1)
By Molecule Type (1)
By Therapeutic Area (3)
Covance Events (9)
Geography (3)
Keywords (10)

Filters

Showing results 97 - 112 of 91813 for .

Showing results 97 - 112 of 91813 for .

Less Gambling, More Science: Phase II Under Scrutiny
Failures of Phase III programs after successful Phase II programs is probably the worst outcome of a clinical development program, as it failed in the most costly way. Nevertheless, these failures occur not infrequently.
Leverage Modern Analytical Methods and Instrumentation to Protect Consumers from Pesticide Residues
Considering the current level of extensive international food trade, food safety has become a significant global issue. Many people are increasingly concerned about chemical residues in their foods.
Wearable Medical Devices: Applying Big Data Into Clinical Trials
As device technology significantly improves and becomes more reliable and user friendly, the range and quality of measurable modalities-from actigraphy (movement or sleep patterns) to respiration-continues to expand.
The Affordable Care Act - Who Has It Helped The Most
A new data set has been published that paints a clear picture of who gained insurance coverage during the 2014 open enrollment period, which ended on April 15, 2014. Recently featured in the New York Times, the data come from Enroll America, a non-profit organization focused on enrolling Americans in health insurance plans, and Civis Analytics, a data analysis firm.
LC-MS/MS Emerges As New Method of Analysis for Vitamin B Testing
Analytical test methods for vitamin testing in foods have been in existence for decades, including microbiological and high performance liquid chromatography (HPLC) methods.
Price Disparity: Will It Ever Truly Disappear?
Geographic price disparity between pharmaceutical products exists due to the variation in national economies and the unique ways that each country determines the price of pharmaceuticals.
Your Target Product Profile Can Be the Key to Regulatory Success
Regulatory strategy hinges on having the end in mind from the outset.
The CiPA Debate: What You Should Know
Debate around best practices for safety pharmacology continued on December 11, 2014 as global regulators, drug developers and scientists from contract research organizations gathered in Silver Spring,
Detecting and Quantifying Mycotoxins with LC-MS/MS
With the availability of sensitive mass selective instruments, such as tandem mass spectrometers and high-resolution mass spectrometers, today's food safety chemists have the ability to accurately analyze multiple classes of mytotoxins simultaneously with minimal sample preparation.
Market Access in Asia: What Role for Health Economics?
The pharmaceutical, medical device and diagnostics industries are very interested in the changing market access landscape in South and East Asia because of the vast commercial potential of this area.
Multi-Criteria Decision Analysis in Health Technology Risk-Benefit Analysis: The Future?
Current trends in health technology assessment (HTA) indicate a shift away from the use of cost-effectiveness to value-related measures. A suite of analysis methods,
Establishing Control Over the Manufacturing Process and the Quality of your Biologic
When a patient reads the label on their medicine bottle, he or she naturally relies on the medicine to contain the correct drug, be safe, work as intended and list the correct dosage.
The Growing "Need for Speed" in Food Pathogen Testing
It seems every few months there's another announcement about a new rapid method to test for pathogens. These developments have food manufacturers talking, but why the growing need for speed when it comes to food pathogen testing? And how do you know which method is right for you?
SEND is Here. Are you Ready for Data-Driven Decision Making?
There's no denying that studies are only as strong as their resulting data-and nonclinical studies produce a lot of data.
Are You Really Comparing 'Apples to Apples'? Four Tips For Comparing Food Testing Labs
If you walk into a McDonald's restaurant anywhere in the world, one thing is certain: your hamburger will taste the same. Ensuring that level of consistency in tens of thousands of restaurants is no small feat-and is a testament to the stringent quality and safety practices followed by their suppliers.
Creating your Biomarker Strategy from Discovery to Development
In the effort to reduce attrition rates and improve approval rates of new molecular entities by regulatory agencies, there's no doubt that biomarkers can make a big impact.